Novel active agents in patients with advanced NSCLC without driver mutations who have progressed after first-line chemotherapy

Christian Manegold, Alex Adjei, Federico Bussolino, Federico Cappuzzo, Lucio Crino, Rafal Dziadziuszko, David Ettinger, Dean Fennell, Keith Kerr, Thierry Le Chevalier, Natasha Leighl, Mauro Papotti, Luis Paz-Ares, Maurice Pérol, Solange Peters, Robert Pirker, Elisabeth Quoix, Martin Reck, Egbert Smit, Everett VokesNico Van Zandwijk, Caicun Zhou

Research output: Contribution to journalReview article

4 Scopus citations

Fingerprint Dive into the research topics of 'Novel active agents in patients with advanced NSCLC without driver mutations who have progressed after first-line chemotherapy'. Together they form a unique fingerprint.

Medicine & Life Sciences